Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vermillion Inc (VRML)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,388
  • Shares Outstanding, K 75,270
  • Annual Sales, $ 3,120 K
  • Annual Income, $ -10,500 K
  • 36-Month Beta 1.23
  • Price/Sales 13.10
  • Price/Cash Flow N/A
  • Price/Book 31.31
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.20
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/15
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +908,281.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.47 +8.51%
on 08/14/18
0.79 -35.44%
on 07/18/18
-0.11 (-17.74%)
since 07/13/18
3-Month
0.47 +8.51%
on 08/14/18
1.28 -60.16%
on 05/15/18
-0.76 (-59.84%)
since 05/14/18
52-Week
0.47 +8.51%
on 08/14/18
2.10 -75.71%
on 12/18/17
-0.79 (-60.77%)
since 08/14/17

Most Recent Stories

More News
Vermillion Reports Second Quarter 2018 Financial Results

Conference Call scheduled for today, August 9, 2018 at 4:30 p.m. ET

VRML : 0.51 (-5.56%)
Vermillion to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Thursday, August 9

Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that it will report financial results for the second quarter and six months ended June...

VRML : 0.51 (-5.56%)
Vermillion Names Chris Goulart to Senior Vice President of Commercial Operations

Newly created position to focus on Company's platform and portfolio growth

VRML : 0.51 (-5.56%)
Vermillion, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Vermillion, Inc. (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 4:30 PM Eastern Time.

VRML : 0.51 (-5.56%)
Vermillion Reports First Quarter 2017 Financial Results

Conference Call scheduled for today, May 14 at 4:30 p.m. ET

VRML : 0.51 (-5.56%)
Vermillion to Report First Quarter 2018 Financial Results on Monday, May 14

Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its first quarter ended March 31, 2018 financial results on Monday,...

VRML : 0.51 (-5.56%)
Vermillion Announces Recognition by and Publication in Two Top Physician Educational Resources

Article highlighting OVA1's biomarker test published in the March 2018 issue of "UpToDate," an evidence-based physician-authored publication

VRML : 0.51 (-5.56%)
Vermillion Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Conference Call at 4:30 p.m. ET Today

VRML : 0.51 (-5.56%)
Vermillion, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 13, 2018 / Vermillion, Inc. (NASDAQ: VRML) will be discussing their earnings results in their Q4 Earnings Call to be held on March 13, 2018, at 4:30 PM Eastern Time.

VRML : 0.51 (-5.56%)
Vermillion to Present at the 30th Annual ROTH Conference

Vermillion, Inc. (Nasdaq:VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that Valerie Palmieri, President and Chief Executive Officer, and Robert Beechey, Chief...

VRML : 0.51 (-5.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade VRML with:

Business Summary

Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide...

See More

Key Turning Points

2nd Resistance Point 0.59
1st Resistance Point 0.55
Last Price 0.51
1st Support Level 0.47
2nd Support Level 0.43

See More

52-Week High 2.10
Fibonacci 61.8% 1.48
Fibonacci 50% 1.28
Fibonacci 38.2% 1.09
Last Price 0.51
52-Week Low 0.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar